These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 28366914)

  • 1. Medical dermatology.
    Warren RB
    Clin Med (Lond); 2008 Apr; 8(2):198-200. PubMed ID: 18478871
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic criteria in dermatology.
    Pragya A N; Juhi S; Jinal T; Dharmesh P
    Indian J Dermatol Venereol Leprol; 2023; 89(5):771-779. PubMed ID: 37067144
    [No Abstract]   [Full Text] [Related]  

  • 3. Burden of Skin and Subcutaneous Diseases in Indonesia 1990 to 2019.
    Prameswari FU; Muharram FR; Setyaningrum T; Prakoeswa CRS
    Acta Derm Venereol; 2023 Dec; 103():adv18291. PubMed ID: 38112210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of β-blockers in dermatological treatment: a review.
    Chen L; Tsai TF
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):363-371. PubMed ID: 28850731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral propranolol and topical timolol in the treatment of post-burn pyogenic granuloma: Two cases and a review of the literature.
    Ebrahimi Z; Mahdi Z; Khairi AA; Behrangi E; Zare AG; Dehghani A; Goodarzi A
    Clin Case Rep; 2022 Nov; 10(11):e6538. PubMed ID: 36439384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosacea Treatment: Review and Update.
    Zhang H; Tang K; Wang Y; Fang R; Sun Q
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):13-24. PubMed ID: 33170491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds.
    Gallegos AC; Davis MJ; Tchanque-Fossuo CN; West K; Eisentrout-Melton A; Peavy TR; Dixon RW; Patel RP; Dahle SE; Isseroff RR
    Adv Wound Care (New Rochelle); 2019 Nov; 8(11):538-545. PubMed ID: 31637100
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic adverse reactions of β-blockers and the skin.
    Tatu AL; Elisei AM; Chioncel V; Miulescu M; Nwabudike LC
    Exp Ther Med; 2019 Aug; 18(2):955-959. PubMed ID: 31384329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What's new in clinical dermatology?].
    Derancourt Ch
    Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S125-36. PubMed ID: 21193116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanodermatology: a bright glimpse just beyond the horizon - part I.
    Nasir A
    Skin Therapy Lett; 2010 Sep; 15(8):1-4. PubMed ID: 20844848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers in dermatology.
    Prabha N; Chhabra N; Arora R
    Indian J Dermatol Venereol Leprol; 2017; 83(3):399-407. PubMed ID: 28366914
    [No Abstract]   [Full Text] [Related]  

  • 12. The future of dermatology: challenges and opportunities.
    Edison KE
    Mo Med; 2007; 104(2):117-8. PubMed ID: 17536438
    [No Abstract]   [Full Text] [Related]  

  • 13. Levamisole: A multi-faceted drug in dermatology.
    Gupta M
    Indian J Dermatol Venereol Leprol; 2016; 82(2):230-6. PubMed ID: 26924410
    [No Abstract]   [Full Text] [Related]  

  • 14. Intralesional drug therapy in dermatology.
    Deshmukh NS; Belgaumkar VA; Mhaske CB; Doshi BR
    Indian J Dermatol Venereol Leprol; 2017; 83(1):127-132. PubMed ID: 27647355
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.